Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OP-1 osteogenic protein-1 data

CBMI (Hopkinton, Mass.) announced that its further analysis of a pilot trial has shown statistical evidence of new dentin formation (p

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE